Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'pioglitazone' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 137 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Smith, U
      Pioglitazone: mechanism of action

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. Kaplan, F; Al-Majali, K; Betteridge, DJ
      PPARs, insulin resistance and type 2 diabetes

      JOURNAL OF CARDIOVASCULAR RISK
    3. Scheen, AJ
      Thiazolidinediones and liver toxicity

      DIABETES & METABOLISM
    4. Blickle, JF
      Thiazolidinediones: clinical data and perspectives

      DIABETES & METABOLISM
    5. Halimi, S
      Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?

      DIABETES & METABOLISM
    6. Collins, AR; Meehan, WP; Kintscher, U; Jackson, S; Wakino, S; Noh, G; Palinski, W; Hsueh, WA; Law, RE
      Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    7. Rosenblatt, S; Miskin, B; Glazer, NB; Prince, MJ; Robertson, KE
      The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

      CORONARY ARTERY DISEASE
    8. Sugawara, A; Takeuchi, K; Uruno, A; Ikeda, Y; Arima, S; Sato, K; Kudo, M; Taniyama, Y; Ito, S
      Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes

      Hypertension research
    9. Kushibiki, S; Hodate, K; Shingu, H; Ueda, Y; Shinoda, M; Mori, Y; Itoh, T; Yokomizo, Y
      Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione

      DOMESTIC ANIMAL ENDOCRINOLOGY
    10. Perfetti, R; Chamie, K
      Enhancing insulin action: From chemical elements to thiazolidinediones

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    11. Yoshida, K; Kohzuki, M; Xu, HL; Wu, XM; Kamimoto, M; Sato, T
      Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure

      JOURNAL OF HYPERTENSION
    12. Tsuji, T; Mizushige, K; Noma, T; Murakami, K; Ohmori, K; Miyatake, A; Kohno, M
      Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    13. Goetze, S; Kintscher, U; Kim, S; Meehan, WP; Kaneshiro, K; Collins, AR; Fleck, E; Hsueh, WA; Law, RE
      Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    14. Chilcott, J; Tappenden, P; Jones, ML; Wight, JP
      A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

      CLINICAL THERAPEUTICS
    15. Kramer, D; Shapiro, R; Adler, A; Bush, E; Rondinone, CM
      Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats

      METABOLISM-CLINICAL AND EXPERIMENTAL
    16. Bebernitz, GR; Argentieri, G; Battle, B; Brennan, C; Balkan, B; Burkey, BF; Eckhardt, M; Gao, JP; Kapa, P; Strohschein, RJ; Schuster, HF; Wilson, M; Xu, DD
      The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilizationin ob/ob mice

      JOURNAL OF MEDICINAL CHEMISTRY
    17. Fukunaga, Y; Itoh, H; Doi, K; Tanaka, T; Yamashita, J; Chun, TH; Inoue, M; Masatsugu, K; Sawada, N; Saito, T; Hosoda, K; Kook, H; Ueda, M; Nakao, K
      Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

      ATHEROSCLEROSIS
    18. Janka, HU
      Glitazone - Profile of a new class of substances

      INTERNIST
    19. Itami, A; Watanabe, G; Shimada, Y; Hashimoto, Y; Kawamura, J; Kato, M; Hosotani, R; Imamura, M
      Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo

      INTERNATIONAL JOURNAL OF CANCER
    20. Niiya, T; Osawa, H; Onuma, H; Suzuki, Y; Taira, M; Yamada, K; Makino, H
      Activation of mouse phosphodiesterase 3B gene promoter by adipocyte differentiation in 3T3-L1 cells

      FEBS LETTERS
    21. Takamura, T; Nohara, E; Nagai, Y; Kobayashi, K
      Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPAR gamma mRNA expression in 3T3-L1 adipocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Goke, R; Goke, A; Goke, B; El-Deiry, WS; Chen, YH
      Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-inducedapoptosis by induction of p21(waf1/cip1)

      DIGESTION
    23. Rieusset, J; Chambrier, C; Bouzakri, K; Dusserre, E; Auwerx, J; Riou, JP; Laville, M; Vidal, H
      The expression of the p85 alpha subunit of phosphatidylinositol 3-Kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes

      DIABETOLOGIA
    24. Oakes, ND; Thalen, PG; Jacinto, SM; Ljung, B
      Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability

      DIABETES
    25. Shintani, M; Nishimura, H; Yonemitsu, S; Ogawa, Y; Hayashi, T; Hosoda, K; Inoue, G; Nakao, K
      Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes

      DIABETES
    26. Furuse, Y; Ogino, K; Shimoyama, M; Sasaki, N; Hisatome, I
      Ca2+-sensitizing effect is involved in the positive inotropic effect of troglitazone

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Klotz, U; Sailer, D
      Drug interactions - their impact on safe drug therapy as exemplified by the novel group of thiazolidinediones (glitazones)

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    28. Mykkanen, L
      Prevention of coronary heart disease in type 2 diabetes

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    29. Tan, MH
      Current treatment of insulin resistance in type 2 diabetes mellitus

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    30. Kawamori, R
      The role of the liver on post-prandial glycaemia - emphasis on hepatic glucose uptake

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    31. Fuchtenbusch, M; Standl, E; Schatz, H
      Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    32. Schatz, H; Massi-Benedetti, M
      Pioglitazone: From development to clinical practice

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    33. Tan, MH
      How pioglitazone affects glucose and lipid metabolism

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    34. Eckland, DA; Danhof, M
      Clinical pharmacokinetics of pioglitazone

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    35. Buse, JB
      Pioglitazone in the treatment of type 2 diabetes mellitus: US clinical experience

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    36. Hanefeld, M; Goke, B
      Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    37. Belcher, G; Matthews, DR
      Safety and tolerability of pioglitazone

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    38. Kimura, M; Daimon, M; Tominaga, M; Manaka, H; Sasaki, H; Kato, T
      Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and Wistar fatty rats

      ENDOCRINE JOURNAL
    39. Grinsell, JW; Lardinois, CK; Swislocki, A; Gonzalez, R; Sare, JS; Michaels, JR; Starich, GH
      Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat

      AMERICAN JOURNAL OF HYPERTENSION
    40. Einhorn, D; Rendell, M; Rosenzweig, J; Egan, JW; Mathisen, AL; Schneider, RL
      Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes melitus: A randomized, placebo-controlled study

      CLINICAL THERAPEUTICS
    41. Yamazaki, Y; Osaka, T; Murakami, T; Inoue, S
      JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats

      METABOLISM-CLINICAL AND EXPERIMENTAL
    42. Suzuki, A; Yasuno, T; Kojo, H; Hirosumi, J; Mutoh, S; Notsu, Y
      Alteration in expression profiles of a series of diabetes-related genes indb/db mice following treatment with thiazolidinediones

      JAPANESE JOURNAL OF PHARMACOLOGY
    43. Katoh, Y; Hashimoto, S; Kimura, J; Watanabe, T
      Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig

      JAPANESE JOURNAL OF PHARMACOLOGY
    44. Okura, T; Nakamura, M; Takata, Y; Watanabe, S; Kitami, Y; Hiwada, K
      Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    45. Uchida, K; Ogino, K; Shimoyama, M; Hisatome, I; Shigemasa, C
      Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts

      EUROPEAN JOURNAL OF PHARMACOLOGY
    46. Gillies, PS; Dunn, CJ
      Pioglitazone

      DRUGS
    47. Rahbar, S; Natarajan, R; Yerneni, KK; Scott, S; Gonzales, N; Nadler, JL
      Evidence that pioglitazone, metformin and pentoxifylline are inhibitors ofglycation

      CLINICA CHIMICA ACTA
    48. Sakamoto, J; Kimura, H; Moriyama, S; Odaka, H; Momose, Y; Sugiyama, Y; Sawada, H
      Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    49. Subramaniam, S
      The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    50. Ishikawa, Y; Takeno, H; Watanabe, K; Tani, T
      Lipogenic action of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic KK-Ay mice

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    51. Day, C
      Thiazolidinediones: a new class of antidiabetic drugs

      DIABETIC MEDICINE
    52. Takamura, T; Ando, H; Nagai, Y; Yamashita, H; Nohara, E; Kobayashi, K
      Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes

      DIABETES RESEARCH AND CLINICAL PRACTICE
    53. Yoshimoto, T; Naruse, M; Shizume, H; Naruse, K; Tanabe, A; Tanaka, M; Tago, K; Irie, K; Muraki, T; Demura, H; Zardi, L
      Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy

      ATHEROSCLEROSIS
    54. Sunaga, Y; Inagaki, N; Gonoi, T; Yamada, Y; Ishida, H; Seino, Y; Seino, S
      Troglitazone but not pioglitazone affects ATP-sensitive K+ channel activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    55. Shibata, T; Matsui, K; Yonemori, F; Wakitani, K
      Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501

      EUROPEAN JOURNAL OF PHARMACOLOGY
    56. Knock, GA; Mishra, SK; Aaronson, PI
      Differential effects of insulin-sensitizers troglitazone and rosiglitazoneon ion currents in rat vascular myocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    57. Shibata, T; Matsui, K; Nagao, K; Shinkai, H; Yonemori, F; Wakitani, K
      Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative

      EUROPEAN JOURNAL OF PHARMACOLOGY
    58. Maegawa, H; Obata, T; Shibata, T; Fujita, T; Ugi, S; Morino, K; Nishio, Y; Kojima, H; Hidaka, H; Haneda, R; Yasuda, H; Kikkawa, R; Kashiwagi, A
      A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle

      DIABETOLOGIA
    59. Walker, AB; Chattington, PD; Buckingham, RE; Williams, G
      The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats

      DIABETES
    60. Shimoyama, M; Ogino, K; Tanaka, Y; Ikeda, T; Hisatome, I
      Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts

      DIABETES
    61. Asano, M; Nakajima, T; Iwasawa, K; Morita, T; Nakamura, F; Imuta, H; Chisaki, K; Yamada, N; Omata, M; Okuda, Y
      Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells

      BRITISH JOURNAL OF PHARMACOLOGY
    62. Paul, M
      Modes of action and clinical efficacy of pioglitazone as a new principle for the treatment of type 2 diabetes

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    63. FUJISHIMA S; OHYA Y; NAKAMURA Y; ONAKA U; ABE I; FUJISHIMA M
      TROGLITAZONE, AN INSULIN SENSITIZER, INCREASES FOREARM BLOOD-FLOW IN HUMANS

      American journal of hypertension
    64. PUGAZHENTHI S; KHANDELWAL RL
      INSULIN ACTION ON PROTEIN PHOSPHATASE-1 ACTIVATION IS ENHANCED BY THEANTIDIABETIC AGENT PIOGLITAZONE IN CULTURED DIABETIC HEPATOCYTES

      Molecular and cellular biochemistry
    65. GOUD C; PITT B; WEBB RC; RICHEY JM
      SYNERGISTIC ACTIONS OF INSULIN AND TROGLITAZONE ON CONTRACTILITY IN ENDOTHELIUM-DENUDED RAT AORTIC RINGS

      American journal of physiology: endocrinology and metabolism
    66. ISHIKAWA Y; SAITO MNI; IKEMOTO T; TAKENO H; WATANABE K; TANI T
      ACTIONS OF THE NOVEL ORAL ANTIDIABETIC AGENT HQL-975 IN INSULIN-RESISTANT NON-INSULIN-DEPENDENT DIABETES-MELLITUS MODEL ANIMALS

      Diabetes research and clinical practice
    67. KAWAMORI R; MATSUHISA M; KINOSHITA J; MOCHIZUKI K; NIWA M; ARISAKA T; IKEDA M; KUBOTA M; WADA M; KANDA T; IKEBUCHI M; TOHDA R; YAMASAKI Y
      PIOGLITAZONE ENHANCES SPLANCHNIC GLUCOSE-UPTAKE AS WELL AS PERIPHERALGLUCOSE-UPTAKE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Diabetes research and clinical practice
    68. VERMA S; BHANOT S; ARIKAWA E; YAO LF; MCNEILL JH
      DIRECT VASODEPRESSOR EFFECTS OF PIOGLITAZONE IN SPONTANEOUSLY HYPERTENSIVE RATS

      Pharmacology
    69. SUGIMOTO M; TAKEDA N; NAKASHIMA K; OKUMURA S; TAKAMI K; YOSHINO K; HATTORI J; ISHIMORI M; TAKAMI R; SASAKI A; YASUDA K
      EFFECTS OF TROGLITAZONE ON HEPATIC AND PERIPHERAL INSULIN-RESISTANCE INDUCED BY GROWTH-HORMONE EXCESS IN RATS

      Metabolism, clinical and experimental
    70. OKUMURA S; TAKEDA N; TAKAMI K; YOSHINO K; HATTORI J; NAKASHIMA K; SUGIMOTO M; ISHIMORI M; TAKAMI R; YASUDA K
      EFFECTS OF TROGLITAZONE ON DEXAMETHASONE-INDUCED INSULIN-RESISTANCE IN RATS

      Metabolism, clinical and experimental
    71. Thuillier, P; Baillie, R; Sha, XM; Clarke, SD
      Cytosolic and nuclear distribution of PPAR gamma 2 in differentiating 3T3-L1 preadipocytes

      JOURNAL OF LIPID RESEARCH
    72. OBATA T; MAEGAWA H; KASHIWAGI A; PILLAY TS; KIKKAWA R
      HIGH GLUCOSE-INDUCED ABNORMAL EPIDERMAL GROWTH-FACTOR SIGNALING

      Journal of Biochemistry
    73. KIHARA S; OUCHI N; FUNAHASHI T; SHINOHARA E; TAMURA R; YAMASHITA S; MATSUZAWA Y
      TROGLITAZONE ENHANCES GLUCOSE-UPTAKE AND INHIBITS MITOGEN-ACTIVATED PROTEIN-KINASE IN HUMAN AORTIC SMOOTH-MUSCLE CELLS

      Atherosclerosis
    74. SHIMAYA A; KUROSAKI E; SHIODUKA K; NAKANO R; SHIBASAKI M; SHIKAMA H
      YM268 INCREASES THE GLUCOSE-UPTAKE, CELL-DIFFERENTIATION, AND MESSENGER-RNA EXPRESSION OF GLUCOSE-TRANSPORTER IN 3T3-L1 ADIPOCYTES

      Hormone and Metabolic Research
    75. IKEDA S; WATANABE T
      EFFECTS OF TROGLITAZONE AND PIOGLITAZONE ON THE ACTION-POTENTIALS ANDMEMBRANE CURRENTS OF RABBIT VENTRICULAR MYOCYTES

      European journal of pharmacology
    76. SU TZ; WANG M; OXENDER DL; SALTIEL AR
      TROGLITAZONE INCREASES SYSTEM-A AMINO-ACID-TRANSPORT IN 3T3-L1 CELLS

      Endocrinology
    77. MURASE K; ODAKA H; SUZUKI M; TAYUKI N; IKEDA H
      PIOGLITAZONE TIME-DEPENDENTLY REDUCES TUMOR-NECROSIS-FACTOR-ALPHA LEVEL IN MUSCLE AND IMPROVES METABOLIC ABNORMALITIES IN WISTAR FATTY RATS

      Diabetologia
    78. WALKER AB; NADERALI EK; CHATTINGTON PD; BUCKINGHAM RE; WILLIAMS G
      DIFFERENTIAL VASOACTIVE EFFECTS OF THE INSULIN SENSITIZERS ROSIGLITAZONE (BRL-49653) AND TROGLITAZONE ON HUMAN SMALL ARTERIES IN-VITRO

      Diabetes
    79. MATSUDA J; HOSODA K; ITOH H; SON C; DOI K; HANAOKA I; INOUE G; NISHIMURA H; YOSHIMASA Y; YAMORI Y; ODAKA H; NAKAO K
      INCREASED ADIPOSE EXPRESSION OF THE UNCOUPLING PROTEIN-3 GENE BY THIAZOLIDINEDIONES IN WISTAR FATTY RATS AND IN CULTURED ADIPOCYTES

      Diabetes
    80. ARAKAWA K; ISHIHARA T; AOTO M; INAMASU M; SAITO A; IKEZAWA K
      ACTIONS OF NOVEL ANTIDIABETIC THIAZOLIDINEDIONE, T-174, IN ANIMAL-MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) AND IN CULTUREDMUSCLE-CELLS

      British Journal of Pharmacology
    81. NAKAMURA Y; OHYA Y; ONAKA U; FUJII K; ABE I; FUJISHIMA M
      INHIBITORY-ACTION OF INSULIN-SENSITIZING AGENTS ON CALCIUM CHANNELS IN SMOOTH-MUSCLE CELLS FROM RESISTANCE ARTERIES OF GUINEA-PIG

      British Journal of Pharmacology
    82. UEDA N; NOMURA Y; MUTA Y; MATSUZAKI Y; HAYASHIBE M; INO Y; SUZUKI S; KURUMI M
      PHARMACOLOGICAL AND PHARMACOKINETIC STUDIES OF THE NEWLY SYNTHESIZED THIAZOLIDINEDIONE DERIVATIVE ROPANECARBONYLAMINO)BENZYL)-THIAZOLIDINE-2,4-DIONE

      Arzneimittel-Forschung
    83. ISHIKAWA Y; WATANABE K; TAKENO H; TANI T
      EFFECTS OF THE NOVEL ORAL ANTIDIABETIC AGENT HQL-975 ON GLUCOSE AND LIPID-METABOLISM IN DIABETIC DB DB MICE/

      Arzneimittel-Forschung
    84. NISHIMURA Y; INOUE Y; TAKEUCHI H; OKA Y
      ACUTE EFFECTS OF PIOGLITAZONE ON GLUCOSE-METABOLISM IN PERFUSED-RAT-LIVER

      Acta diabetologica
    85. KOTCHEN TA; REDDY S; ZHANG HY
      INCREASING INSULIN SENSITIVITY LOWERS BLOOD-PRESSURE IN THE FRUCTOSE-FED RAT

      American journal of hypertension
    86. SAKU K; ZHANG B; OHTA T; ARAKAWA K
      TROGLITAZONE LOWERS BLOOD-PRESSURE AND ENHANCES INSULIN SENSITIVITY IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS

      American journal of hypertension
    87. MORIKANG E; BENSON SC; KURTZ TW; PERSHADSINGH HA
      EFFECTS OF THIAZOLIDINEDIONES ON GROWTH AND DIFFERENTIATION OF HUMAN AORTA AND CORONARY MYOCYTES

      American journal of hypertension
    88. CIARALDI T; HENRY RR
      THIAZOLIDINEDIONES AND THEIR EFFECTS ON GLUCOSE TRANSPORTERS

      European journal of endocrinology
    89. SHIMAYA A; NOSHIRO O; HIRAYAMA R; YONETA T; NIIGATA K; SHIKAMA H
      INSULIN SENSITIZER YM268 AMELIORATES INSULIN-RESISTANCE BY NORMALIZING THE DECREASED CONTENT OF GLUT4 IN ADIPOSE-TISSUE OF OBESE ZUCKER RATS

      European journal of endocrinology
    90. HUFF BE; LEFFELMAN CL; LETOURNEAU ME; SULLIVAN KA; WARD JA; STILLE JR
      SYNTHETIC APPROACHES TO BENZOFURAN CONTAINING INSULIN SENSITIVITY ENHANCER COMPOUNDS FOR TREATMENT OF TYPE-II DIABETES

      Heterocycles
    91. NOSHIRO O; HIRAYAMA R; SHIMAYA A; YONETA T; NIIGATA K; SHIKAMA H
      ROLE OF PLASMA-INSULIN CONCENTRATION IN REGULATING GLUCOSE AND LIPID-METABOLISM IN LEAN AND OBESE ZUCKER RATS

      International journal of obesity
    92. YAMASAKI Y; KAWAMORI R; WASADA T; SATO A; OMORI Y; EGUCHI H; TOMINAGA M; SASAKI H; IKEDA M; KUBOTA M; ISHIDA Y; HOZUMI T; BABA S; UEHARA M; SHICHIRI M; KANEKO T
      PIOGLITAZONE (AD-4833) AMELIORATES INSULIN-RESISTANCE IN PATIENTS WITH NIDDM

      Tohoku Journal of Experimental Medicine
    93. WEINSTOCK RS; MURRAY FT; DIANI A; SANGANI GA; WACHOWSKI MB; MESSINA JL
      PIOGLITAZONE - IN-VITRO EFFECTS ON RAT HEPATOMA-CELLS AND IN-VIVO LIVER HYPERTROPHY IN KKA(Y) MICE

      Pharmacology
    94. OAKES ND; CAMILLERI S; FURLER SM; CHISHOLM DJ; KRAEGEN EW
      THE INSULIN SENSITIZER, BRL-49653, REDUCES SYSTEMIC FATTY-ACID SUPPLYAND UTILIZATION AND TISSUE LIPID AVAILABILITY IN THE RAT

      Metabolism, clinical and experimental
    95. MORIMOTO Y; NISHIKAWA K; OHASHI M
      KB-R7785, A NOVEL MATRIX METALLOPROTEINASE INHIBITOR, EXERTS ITS ANTIDIABETIC EFFECT BY INHIBITING TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION

      Life sciences
    96. UCHIDA A; NAKATA T; HATTA T; KIYAMA M; KAWA T; MORIMOTO S; MIKI S; MORIGUCHI J; NAKAMURA K; FUJITA H; ITOH H; SASAKI S; TAKEDA K; NAKAGAWA M
      REDUCTION OF INSULIN-RESISTANCE ATTENUATES THE DEVELOPMENT OF HYPERTENSION IN SUCROSE-FED SHR

      Life sciences
    97. MARTIN G; SCHOONJANS K; LEFEBVRE AM; STAELS B; AUWERX J
      COORDINATE REGULATION OF THE EXPRESSION OF THE FATTY-ACID TRANSPORT PROTEIN AND ACYL-COA SYNTHETASE GENES BY PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS

      The Journal of biological chemistry
    98. SUZUKI M; NOMURA C; ODAKA H; IKEDA H
      EFFECT OF AN INSULIN SENSITIZER, PIOGLITAZONE, ON HYPERTENSION IN FRUCTOSE-DRINKING RATS

      Japanese Journal of Pharmacology
    99. IGARASHI M; TAKEDA Y; ISHIBASHI N; TAKAHASHI K; MORI S; TOMINAGA M; SAITO Y
      PIOGLITAZONE REDUCES SMOOTH-MUSCLE CELL-DENSITY OF RAT CAROTID ARTERIAL INTIMA INDUCED BY BALLOON CATHETERIZATION

      Hormone and Metabolic Research
    100. GRAF K; XI XP; HSUEH WA; LAW RE
      TROGLITAZONE INHIBITS ANGIOTENSIN-II-INDUCED DNA-SYNTHESIS AND MIGRATION IN VASCULAR SMOOTH-MUSCLE CELLS

      FEBS letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 21:52:56